Benign 0 6 0 6 B-cancer
histology 7 16 7 16 O

Conservative 0 12 17 29 B-treatment
surgery 13 20 30 37 I-treatment
to 21 23 38 40 O
the 24 27 41 44 O
target 28 34 45 51 O
site 35 39 52 56 O

Deemed 0 6 57 63 O
appropriate 7 18 64 75 O
for 19 22 76 79 O
preoperative 23 35 80 92 B-treatment
or 36 38 93 95 I-treatment
postoperative 39 52 96 109 I-treatment
radiotherapy 53 65 110 122 I-treatment

Eastern 0 7 123 130 B-clinical_variable
Cooperative 8 19 131 142 I-clinical_variable
Oncology 20 28 143 151 I-clinical_variable
Group 29 34 152 157 I-clinical_variable
( 35 36 158 159 I-clinical_variable
ECOG 36 40 159 163 I-clinical_variable
) 40 41 163 164 I-clinical_variable
score 42 47 165 170 I-clinical_variable
0 48 49 171 172 B-lower_bound
- 49 50 172 173 O
3 50 51 173 174 B-upper_bound

Histologically 0 14 175 189 O
proven 15 21 190 196 O
soft 22 26 197 201 B-cancer
tissue 27 33 202 208 I-cancer
sarcoma 34 41 209 216 I-cancer
of 42 44 217 219 O
the 45 48 220 223 O
extremity 49 58 224 233 O

Patient 0 7 234 241 O
is 8 10 242 244 O
aged 11 15 245 249 B-age
18years 16 23 250 257 B-lower_bound
or 24 26 258 260 O
older 27 32 261 266 O

Patient 0 7 267 274 O
may 8 11 275 278 O
have 12 16 279 283 O
undergone 17 26 284 293 O
excisional 27 37 294 304 B-treatment
biopsy 38 44 305 311 I-treatment
with 45 49 312 316 O
positive 50 58 317 325 O
margins 59 66 326 333 O
at 67 69 334 336 O
a 70 71 337 338 O
referring 72 81 339 348 O
hospital 82 90 349 357 O
and 91 94 358 361 O
are 95 98 362 365 O
eligible 99 107 366 374 O
following 108 117 375 384 O
discussion 118 128 385 395 O
among 129 134 396 401 O
the 135 138 402 405 O
surgical 139 147 406 414 O
oncologists 148 159 415 426 O
and 160 163 427 430 O
radiation 164 173 431 440 O
oncologists 174 185 441 452 O
that 186 190 453 457 O
IMRT 191 195 458 462 B-treatment
is 196 198 463 465 O
an 199 201 466 468 O
acceptable 202 212 469 479 O
treatment 213 222 480 489 O
for 223 226 490 493 O
that 227 231 494 498 O
case 232 236 499 503 O

Planned 0 7 504 511 O
chemotherapy 8 20 512 524 B-treatment
for 21 24 525 528 O
( 25 26 529 530 O
neo)adjuvant 26 38 530 542 O
treatment 39 48 543 552 O

Presence 0 8 553 561 O
of 9 11 562 564 O
regional 12 20 565 573 B-chronic_disease
nodal 21 26 574 579 I-chronic_disease
disease 27 34 580 587 I-chronic_disease
or 35 37 588 590 O
unequivocal 38 49 591 602 O
distant 50 57 603 610 O
metastases 58 68 611 621 O

Prior 0 5 622 627 O
malignancy 6 16 628 638 B-cancer
within 17 23 639 645 O
the 24 27 646 649 O
previous 28 36 650 658 B-upper_bound
five 37 41 659 663 I-upper_bound
years 42 47 664 669 I-upper_bound

Prior 0 5 670 675 B-treatment
radiotherapy 6 18 676 688 I-treatment
to 19 21 689 691 O
the 22 25 692 695 O
target 26 32 696 702 O
site 33 37 703 707 O

concurrent 0 10 708 718 O
malignancy 11 21 719 729 B-cancer
with 22 26 730 734 O
the 27 30 735 738 O
exception 31 40 739 748 O
of 41 43 749 751 O
adequately 44 54 752 762 O
treated 55 62 763 770 O
basal 63 68 771 776 B-cancer
cell 69 73 777 781 I-cancer
carcinoma 74 83 782 791 I-cancer
of 84 86 792 794 O
the 87 90 795 798 O
skin 91 95 799 803 O
or 96 98 804 806 O
carcinoma 99 108 807 816 B-cancer
in 109 111 817 819 I-cancer
- 111 112 819 820 I-cancer
situ 112 116 820 824 I-cancer
of 117 119 825 827 O
the 120 123 828 831 O
cervix 124 130 832 838 O

conservative 0 12 839 851 B-treatment
surgery 13 20 852 859 I-treatment
following 21 30 860 869 O
patient 31 38 870 877 O
assessment 39 49 878 888 O
by 50 52 889 891 O
a 53 54 892 893 O
radiation 55 64 894 903 B-treatment
oncologist 65 75 904 914 O
and 76 79 915 918 O
surgical 80 88 919 927 O
oncologist 89 99 928 938 O

